Prevention of diabetic nephropathy in mice by a diet low in glycoxidation products

Diabetes/Metabolism Research and Reviews

Volumn 18, Issue 3, 2002, Pages 224-237

  Zheng, Feng ^a   He, Cijiang ^a   Cai, Weijing ^a   Hattori, Masakazu ^b   Steffes, Michael ^c   Vlassara, Helen ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b JOSLIN DIABETES CENTER   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Advanced glycation; Animal models; Diabetic complication; Food; Kidney

Indexed keywords

ADVANCED GLYCATION END PRODUCT; COLLAGEN TYPE 4; LAMININ; MESSENGER RNA; PROTEIN; TRACE ELEMENT; TRANSFORMING GROWTH FACTOR BETA1;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL FOOD; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; CALORIE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIETARY INTAKE; FEMALE; FOOD INTAKE; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY CORTEX; MACRONUTRIENT; MALE; MOUSE; MOUSE STRAIN; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PARAMETER; PRIORITY JOURNAL; RANDOMIZATION; SURVIVAL; TISSUE INJURY; TISSUE LEVEL; ALBUMINURIA; ANIMAL; BLOOD; CARBOHYDRATE DIET; DIABETIC DIET; DIET THERAPY; DISEASE MODEL; GLOMERULUS; KIDNEY; NONOBESE DIABETIC MOUSE; PATHOLOGY; POLYMERASE CHAIN REACTION; URINE;

ALBUMINURIA; ANIMAL; DIABETES MELLITUS, INSULIN-DEPENDENT; DIABETIC DIET; DIABETIC NEPHROPATHIES; DIETARY CARBOHYDRATES; DISEASE MODELS, ANIMAL; GLYCOSYLATION END PRODUCTS, ADVANCED; KIDNEY; KIDNEY GLOMERULUS; MICE; MICE, INBRED NOD; POLYMERASE CHAIN REACTION; SUPPORT, U.S. GOV'T, P.H.S.; ANIMALS; DIABETES MELLITUS, TYPE 1;

EID: 0035985243     PISSN: 15207552     EISSN: None     Source Type: Journal    
DOI: 10.1002/dmrr.283     Document Type: Article

References (56)

1. Dietary factors in the aetiology of diabetes
2. Putative environmental factors in type I diabetes
3. Long-term prognosis of diabetic patients with myocardial infarction: Relation to antidiabetic treatment regimen
4. Dietary treatment of diabetic nephropathy with chronic renal failure
5. Dietary therapy in uremia: The impact on nutrition and progressive renal failure
6. A randomized trial of improved weight loss with a prepared meal plan in overweight and obese patients: Impact on cardiovascular risk reduction
7. Physical Activity and Health: A Report of the Surgeon General
8. Caloric restriction and aging: An update
9. Chronic nephropathy in ad libitum overfed Sprague- Dawley rats and its early attenuation by increasing degrees of dietary (caloric) restriction to control growth
10. Caloric restriction in rhesus monkeys reduces low density lipoprotein interaction with arterial proteoglycans
11. Maillard Reactions in Chemistry, Food and Health. Ketoaldehyde detoxification enzymes and protection against the Maillard reaction
12. Orally absorbed reactive glycation products (glycotoxins) - A potential risk factor in diabetic nephropathy
13. Dietary glycotoxins: Inhibition of reactive products by aminoguanidine facilitates renal clearance and reduces tissue sequestration
14. Maillard reaction- mediated molecular damage to extracellular matrix and other tissue proteins in diabetes, aging and uremia
15. Pathogenic effects of advanced glycosylation: Biochemical, biological and clinical implications for diabetes and aging
16. Ultrastructure of nonenzymatically glycated mesangial matrix in diabetic nephropathy
17. The effect of nonenzymatic glucosylation on the binding of the main noncollagenous NCI domain to type IV collagen
18. Development of glomerular lesions in experimental long-term diabetes in the rat
19. Advanced glycation end products up-regulate gene-expression found in diabetic glomerular disease
20. Receptor-specific increase in extraceflular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via platelet-derived growth factor
21. Cellular receptors for advanced glycation end products: Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions
22. Prevention of glomerular basement membrane thickening by aminoguanidine in experimental diabetes mellitus
23. Progression of nephropathy in spontaneous diabetic rats is prevented by OPB-9195, a novel inhibitor of advanced glycation
24. Methylglyoxal modification of protein. Chemical and immunochemical characterization of methylglyoxalarginine adducts
25. Carboxymethylethanolamine, a biomarker of phospholipid modification during the Maillard reaction in vivo
26. Glycoxidation in aortic collagen from STZ-induced diabetic rats and its relevance to vascular damage
27. The role of AGEs in aging: Causation or correlation
28. Advanced glycation and lipoxidation end products: Role of reactive carbonyl compounds generated during carbohydrate and lipid metabolism
29. The role of the Maillard Reaction in the food industry
30. New aspects of the Maillard reaction in foods and in the human body
31. The interaction of lipid-derived aldehydes with the Maillard reaction in meat systems
32. Monoclonal antibodies specific for advanced glycosylation endproducts in biological samples
33. Standardizing the immunological measurement of advanced glycation endproducts using normal human serum
34. Reduction of plasma apolipoprotein-B by effective removal of circulating glycation derivatives in uremia
35. Depletion of reactive advanced glycation endproducts from diabetic uremic sera using a lysozyme-linked matrix
36. Enzymatic and chemical method for the determination of glutathione
37. Glomerular lesions in nonobese diabetic mouse: Before and after the onset of hyperglycemia
38. Prevention of diabetic nephropathy in db/db mice with glycated albumin antagonists. A novel treatment strategy
39. Differential expression of renal AGE-receptor genes in NOD mice: Possible role in nonobese diabetic renal disease
40. Neutralization of Gro alpha and macrophage inflammatory protein-2 attenuates renal ischemia/reperfusion injury
41. Overexpression of transforming growth factor-beta 1 mRNA is associated with upregulation of glomerular tenascin and lammin gene expression in nonobese diabetic mice
42. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
43. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study
44. United Kingdom Prospective Diabetes Study (UKPDS): What now or so what?
45. Low-dose ramipril reduces microalbuminuria in type 1 diabetic patients without hypertension: Results of a randomized controlled trial
46. Smoking: A factor promoting onset and progression of diabetic nephropathy
47. Volatile compounds produced in Maillard reactions involving cysteine, ribose and phospholipid
48. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage
49. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins
50. Benfotiamine inhibits intracellular formation of advanced glycation endproducts in vivo
51. Alterations in tissue glutathione antioxidant system in streptozotocin-induced diabetic rats
52. Pyridoxamine, an inhibitor of advanced glycation reactions, also inhibits advanced lipoxidation reactions. Mechanism of action of pyridoxamine